Comments on “Preventive home therapy for symptomatic patients affected by COVID-19 and followed by teleconsultations” by D’Amato et al.
We have read with interest the letter from D’Amato et al. entitled “Preventive home therapy for symptomatic patients affected by COVID-19 and followed by teleconsultations”....
D'Amato G, Acanfora L, Delli Paoli L, D'Amato M. Preventive home therapy for symptomatic patients affected by COVID-19 and followed by teleconsultations. Multidisc Respir Med 2021;16:748.
Pirro M. Covid, svolta con la terapia napoletana: «Medicinali subito e nessun decesso». Available from: https://www.ilmattino.it/primopiano/sanita/coronavirus_terapia_napoletana-5726333.html
Horby P, Lim WS, Emberson JR, et al. Dexamethasone in hospitalized patients with Covid-19 - Preliminary report. Epub 2020 Jul 17. N Engl J Med 2021;384:693-704.
Yang Z, Liu J, Zhou Y, et al. The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis. J Infect 2020;81:e13-e20. DOI: https://doi.org/10.1016/j.jinf.2020.03.062
Li H, Chen C, Hu F, et al. Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis. Leukemia 2020;34:1503-11. DOI: https://doi.org/10.1038/s41375-020-0848-3
Monedero P, Gea A, Castro P, Candela-Toha AM, Hernández-Sanz ML, Arruti E, et al. Early corticosteroids are associated with lower mortality in critically ill patients with COVID-19: a cohort study. Crit Care 2021;25:2. DOI: https://doi.org/10.1186/s13054-020-03422-3
Theoharides TC, Conti P. Dexamethasone for COVID-19? Not so fast. J Biol Regul Homeost Agents 2020;34:1241-3.
Khider L, Soudet S, Laneelle D, et al. Proposal of the French Society of Vascular Medicine for the prevention, diagnosis and treatment of venous thromboembolic disease in outpatients with COVID-19. J Med Vasc 2020;45:210-3.
Abdel-Maboud M, Menshawy A, Elgebaly A, Bahbah EI, El Ashal G, Negida A. Should we consider heparin prophylaxis in COVID-19 patients? a systematic review and meta-analysis. J Thromb Thrombolysis 2020. Online Ahead of Print. DOI: https://doi.org/10.1007/s11239-020-02253-x
National Institutes of Health. COVID-19 Treatment Guidelines. Antithrombotic Therapy in Patients with COVID-19. Last Updated: December 17, 2020. Available from: https://www.covid19treatmentguidelines.nih.gov/adjunctive-therapy/antithrombotic-therapy/
Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, et al. COVID-19 and thrombotic or thromboembolic disease: Implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J Am Coll Cardiol 2020;75:2950–73. DOI: https://doi.org/10.1016/j.jacc.2020.04.031
Italian Medicines Agency (AIFA). Low molecular weight heparins in the treatment of adult patients with COVID-19. Update: 24 November 2020. Available from: https://www.aifa.gov.it/documents/20142/1267737/Low-molecular-weight-heparins_EN_24.11.2020.pdf/fc92d837-e27a-17af-18db-9a8635fb19d5
- Abstract views: 43
- PDF: 10
Copyright (c) 2021 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.